ResearchMoz

Bladder Cancer Market Research Reports & Industry Analysis

Bladder Cancer Market Research Reports & Industry Analysis Bladder Cancer

Browse reports in Bladder Cancer

Displaying 1 to 12 (of 12 records)
Iressa (Bladder Cancer) - Analysis and Forecast to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Iressa (Bladder Cancer) - Analysis and Forecast to 2020 provides Iressa global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Bladder Cancer market. This...
$2000
Ellence (Bladder Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Ellence (Bladder Cancer) Analysis and Forecasts to 2020 provides Ellence EU sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2012). The report also includes information on Bladder Cancer market. This report...
$2000
Tykerb (Bladder Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Tykerb (Bladder Cancer) Analysis and Forecasts to 2020 provides Tykerb global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Bladder Cancer market. This...
$2000
Eoquin (Bladder Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Eoquin (Bladder Cancer) Analysis and Forecasts to 2020 provides Eoquin global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Bladder Cancer market. This...
$2000
Javlor (Bladder Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Javlor (Bladder Cancer) Analysis and Forecasts to 2020 provides Javlor global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2010-2020). The report also includes information on Bladder Cancer market. This...
$2000
Mitomycin (Bladder Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Mitomycin (Bladder Cancer) Analysis and Forecasts to 2020 provides Javlor global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Bladder Cancer market. This...
$2000
MVAC (Bladder Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, MVAC (Bladder Cancer) Analysis and Forecasts to 2020 provides MVAC global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Bladder Cancer market. This report is...
$2000
BCG (Bladder Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, BCG (Bladder Cancer) Analysis and Forecasts to 2020 provides BCG global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Bladder Cancer market. This report is...
$2000
Gemzar (Bladder Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Gemzar (Bladder Cancer) Analysis and Forecasts to 2020 provides Gemzar global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Bladder Cancer market. This...
$2000
Thiotepa (Bladder Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Thiotepa (Bladder Cancer) Analysis and Forecasts to 2020 provides Thiotepa global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Bladder Cancer market. This...
$2000
Urocidin (Bladder Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Urocidin (Bladder Cancer) Analysis and Forecasts to 2020 provides Urocidin global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2012-2020). The report also includes information on Bladder Cancer market. This...
$2000
Valstar (Bladder Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Valstar (Bladder Cancer) Analysis and Forecasts to 2020 provides Valstar global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2009-2020). The report also includes information on Bladder Cancer market. This...
$2000
 
Displaying 1 to 12 (of 12 records)